Intravaginal immunization using the recombinant HIV-1 clade-C trimeric envelope glycoprotein CN54gp140 formulated within lyophilized solid dosage forms
Open Access
- 15 June 2011
- Vol. 29 (27) , 4512-4520
- https://doi.org/10.1016/j.vaccine.2011.04.023
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Vaginal delivery of the recombinant HIV-1 clade-C trimeric gp140 envelope protein CN54gp140 within novel rheologically structured vehicles elicits specific immune responsesVaccine, 2009
- Repeated vaginal administration of trimeric HIV-1 clade C gp140 induces serum and mucosal antibody responsesMucosal Immunology, 2009
- Characterization of the Rheological, Mucoadhesive, and Drug Release Properties of Highly Structured Gel Platforms for Intravaginal Drug DeliveryBiomacromolecules, 2009
- Vaginal Drug Delivery Systems for HIV PreventionThe AAPS Journal, 2009
- Structural definition of a conserved neutralization epitope on HIV-1 gp120Nature, 2007
- Human Immunodeficiency Virus Type 1envClones from Acute and Early Subtype B Infections for Standardized Assessments of Vaccine-Elicited Neutralizing AntibodiesJournal of Virology, 2005
- Propagation and Dissemination of Infection after Vaginal Transmission of Simian Immunodeficiency VirusJournal of Virology, 2005
- Nasal and Vaginal Vaccinations Have Differential Effects on Antibody Responses in Vaginal and Cervical Secretions in HumansInfection and Immunity, 2001
- Near Full-Length Clones and Reference Sequences for Subtype C Isolates of HIV Type 1 from Three Different ContinentsAIDS Research and Human Retroviruses, 2001
- Interactions of Stabilizers with Proteins During Freezing and DryingPublished by American Chemical Society (ACS) ,1994